100 episodes in and we’re tackling one of the most critical shifts in the industry.

In Episode 100 of the Orange Pill Podcast, we break down recent FDA enforcement actions from CDER’s BIMO program that reveal a hard truth:

Your supplement can become a drug- based on how you study it.

From enrolling diseased populations without an IND to unethical consent practices and compromised data integrity, these cases highlight the increasing scrutiny on clinical trials in the wellness space.

If you’re running or planning a study, this episode isn’t optional listening.